LeMaitre Vascular, Inc.· LMAT
🇺🇸 US · MidSP600NASDAQ
- Price
- $105.78
- Day
- +2.09%
- Mkt Cap
- $2.42B
- 52W Range
- $79.40 – $118.01
- Volume
- 394.2K
- Beta
- 0.52
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
LeMaitre Vascular, Inc. (LMAT) Q2 2026 Earnings Call Transcript
Read full article
BURLINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance.
Read full article
LeMaitre Vascular NASDAQ: LMAT reported second-quarter 2026 results marked by 10% organic revenue growth, record operating income and continued expansion of its Artegraft product line, while foreign exchange, Middle East export delays and cardiac allograft supply constraints weighed on sales relative to management's expectations.
Read full article
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.74 per share, missing the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.6 per share a year ago.
Read full article